Headache and biomarkers predictive of vascular disease in a representative sample of US children.

National Institute of Neurological Disorders and Stroke, Bldg 31, Room 8A03, Bethesda, MD 20892-2450, USA.
JAMA Pediatrics (Impact Factor: 4.25). 04/2010; 164(4):358-62. DOI: 10.1001/archpediatrics.2010.17
Source: PubMed

ABSTRACT To examine the association of childhood headache disorders with markers of risk for cardiovascular and cerebrovascular disease.
Information was collected on severe or recurrent headache or migraine in childhood or adolescence and on biomarkers predictive of vascular disease.
The National Health and Nutrition Survey, a nationally representative health survey.
Children or adolescents aged 4 to 19 years (n = 11 770) who took part in the National Health and Nutrition Survey in 1999 through 2004.
Body mass index; levels of C-reactive protein, homocysteine, serum and red blood cell folate, vitamin B(12), methylmalonic acid, total cholesterol, high-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, triglycerides, and uric acid; and platelet count.
Mean values for body mass index, C-reactive protein, and homocysteine were higher in children with than without headaches, and more children with headaches were in the highest quintile of risk for these factors. Serum and red blood cell folate levels were lower in children with headache. More children with headache were in the highest quintile of risk for 3 or more of these factors.
Several important risk factors for long-term vascular morbidity cluster in children and adolescents with severe or recurrent headache or migraine. Further study and screening of children with headaches may permit improved preventive management.


Available from: Karin B Nelson, Apr 06, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Migraine is a highly prevalent and frequently disabling disorder. Since the pathogenesis of this condition has a strong inflammatory component and migraine is significantly associated with cardiovascular disease, we assess whether C-reactive protein (CRP) may be epidemiologically or casually linked with migraine. An electronic search on Medline, Scopus and Web of Science produced 17 studies reporting original data about the epidemiological association between CRP and migraine (1 retrospective, 1 interventional, 14 cross-sectional and 1 both interventional and cross-sectional). When all studies reporting sufficient data about CRP values were pooled (n=12; 6980 cases and 38,975 controls), the concentration of CRP was found to be significantly higher in patients with migraine than in controls (weighted mean difference 1.12 mg/L; 95% CI 1.01-1.25 mg/L; p<0.001). In further analysis of studies containing separate data for migraine with and without aura (n=7), CRP values remained significantly higher in both migraineur patients with aura (n=1939; weighted mean difference 0.88 mg/L; 95% CI 0.63-1.14 mg/L; p<0.001) or without aura (n=2483; weighted mean difference 1.04 mg/L; 95% CI 0.78-1.30 mg/L; p<0.001) when compared with controls (n=29,354). Despite a large inter-study heterogeneity (99.3%), our analysis provides evidence of a potential epidemiological association between increased concentration of CRP and migraine, thus paving the way for further clinical investigations about therapeutic agents that may contextually decrease the risk of cardiovascular disease and reduce the burden of migraine.
    Clinical Chemistry and Laboratory Medicine 04/2014; 59(9). DOI:10.1515/cclm-2014-0011 · 2.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic pain in children is overwhelmingly prevalent and is recognized as a major health concern in this population. A biopsychosocial model has been essential for understanding and treating chronic pain in children for decades through interdisciplinary or multidisciplinary pain programs, with results showing a trend for favorable outcomes. However, despite this trend, there remains a subset of patients who continue to have pain issues and disability that prevents full recovery to an optimally functional life. With our increased understanding of central sensitization, the underlying mechanism that promotes chronic pain, we need to target interventions that will calm and balance the nervous system. With expanded use of nutritional therapies that can reduce inflammation and complementary and alternative medicine modalities that have “centrally acting” nonspecific actions, many of these children may have resolution of symptoms and an improved quality of life. An integrative approach to pain management is particularly applicable in children as it seeks to have a full understanding of the underlying problem, promotes partnership with the patient and the family, and uses evidence-based medicine to employ all appropriate therapeutic approaches, both conventional and alternative.
    Techniques in Regional Anesthesia [amp ] Pain Management 01/2014; DOI:10.1053/j.trap.2014.07.006
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Recent evidence suggests that migraine is associated with an increased risk of cardiovascular disorders, so that it is increasingly hypothesized that this primary form of headache my be linked to thrombotic diseases by some biological pathways and risk factors. Homocysteine, a sulfur-containing molecule, is now recognized as an independent risk factor for a variety of thrombotic disorders, especially ischemic heart disease and stroke. This article is hence aimed to provide an overview of epidemiological evidence about the association between homocysteine and migraine published in cross-sectional, prospective or interventional studies. Overall, the evidence gathered from cross-sectional studies that measured plasma homocysteine levels suggests that the epidemiological link between the plasma concentration of this biomarker and migraine is very weak, at best. Contradictory evidence emerged from interventional studies, in which treatment of hyperhomocysteinemia with folic acid or vitamin B supplementation was effective to lower plasma homocysteine and decrease frequency and/or severity of migraine. The association remains largely speculative, however, since it could not be clearly demonstrated that these two biological effects were directly linked. The only study that has assessed homocysteine in cerebrospinal fluid reported that the concentration of this biomarker in migraine patients was significantly increased compared to controls. Although this evidence must be obviously confirmed in larger trials, some putative mechanisms may support a causal link between increased generation of homocysteine in the brain environment and migraine.
    Clinica chimica acta; international journal of clinical chemistry 03/2014; 433. DOI:10.1016/j.cca.2014.02.028 · 2.76 Impact Factor